Olive Diagnostics
Jerusalem
About Olive Diagnostics
It's About me (IAM) has developed a passive sensor mounted to the rim of the toilet that performs urinalysis every time the end-user urinates. The information is uploaded to a robust data science platform to track existing and progressing conditions. Real-time, actionable notifications will be sent to the end user for proactive medical or nutritional care. Ongoing biomarker tracking for hydration, Alcohol, Pregnancy, Ovulation, Keytones, etc. is used to develop a comprehensive personal user profile. The technology will also be used for pharma and CRO companies to track the usage of drugs. While drug compliance issues plague health care systems around the world, I AM's technology will provide a reliable and continuous solution for tracking when and how people take their medicine or clinical trial drug. Nonindustrial nations will now have home access to urine lab services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: Seed
- Last round: Grant (Jan 2023)
- Website: olive.earth
- Phone: +972544218580
Industries & Categories
Artificial Intelligence (AI), Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/olive-diagnostics-54544 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.